What is the official website of Merck ?

The official website of Merck is http://merck.us/2J2xAUh.

What is Merck's cybersecurity risk score?

Merck has an AI-generated cybersecurity risk score of 802 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has Merck experienced?

According to Rankiteo, Merck currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Merck been affected by any supply chain cyber incidents ?

According to Rankiteo, Merck has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Merck have SOC 2 Type 1 certification ?

According to Rankiteo, Merck is not certified under SOC 2 Type 1.

Does Merck have SOC 2 Type 2 certification ?

According to Rankiteo, Merck does not hold a SOC 2 Type 2 certification.

Does Merck comply with GDPR ?

According to Rankiteo, Merck is not listed as GDPR compliant.

Does Merck have PCI DSS certification ?

According to Rankiteo, Merck does not currently maintain PCI DSS compliance.

Does Merck comply with HIPAA ?

According to Rankiteo, Merck is not compliant with HIPAA regulations.

Does Merck have ISO 27001 certification ?

According to Rankiteo,Merck is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Merck operate in ?

Merck operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Merck have ?

Merck employs approximately 44,762 people worldwide.

Does Merck own any subsidiaries ?

Merck presently has no subsidiaries across any sectors.

How many LinkedIn followers does Merck have ?

Merck's official LinkedIn profile has approximately 2,635,829 followers.

What is the NAICS classification code for Merck ?

Merck is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Merck have a Crunchbase profile ?

No, Merck does not have a profile on Crunchbase.

Does Merck have a LinkedIn profile ?

Yes, Merck maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/merck.

How many cybersecurity incidents has Merck experienced ?

As of August 1, 2026, Rankiteo reports that Merck has experienced 3 cybersecurity incidents.

How many peer or competitor companies does Merck have ?

Merck has an estimated 5,720 peer or competitor companies worldwide.

What types of cybersecurity incidents has Merck faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Merck

Boost Score +25 with badge (5 left)

802

/1000

Good

827

/1000

Good

Merck Vendor Cyber Rating & Cyber Score

merck.us

Add Your Compliance Badge

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit

Merck A.I CyberSecurity Scoring

Scoring History

Merck

Merck CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Merck

Breach

9/2025

MER350243511182...

Merck

Cyber Attack

100

6/2025

MER1775377932

Merck

Cyber Attack

06/2017

MER1502422

Loading…

A.I.

Merck Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Merck

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Merck in 2026.

Incident Types Merck vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck in 2026.

Incident History - Merck (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Merck Subsidiaries

Merck

Pharmaceutical Manufacturing

Website: http://merck.us/2J2xAUh

Company Size: 10,000+ employees

Merck Animal HealthPharmaceutical Manufacturing

Merck CanadaPharmaceutical Manufacturing

Loading…

Merck Similar Companies

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Loading…

NEWS

Merck CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

July 02, 2026 07:50 AM

Merck Opens New GCC in Electronic City to House 3,300 Employees: How Will It Impact Nearby Localities?

Merck's new Global Capability Centre in Electronic City will house around 3300 tech and digital professionals. This large-scale facility...

Read Article

July 01, 2026 07:46 AM

Sidley Represents Bio-Techne in Its US$11.3 Billion Acquisition by Merck KGaA

Sidley represented Bio-Techne Corporation (NASDAQ: TECH), a nearly 50-year-old leading provider of life science tools,...

Read Article

June 30, 2026 01:19 PM

US House Committee Opens Investigation Into Merck, AbbVie China Drug Trials

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health...

Read Article

June 30, 2026 11:40 AM

Merck Opens Global Capability Centre in Bengaluru to Expand Digital and Technology Operations

India — Merck Group has inaugurated its new Global Capability Centre (GCC) in Bengaluru, strengthening the company's global digital,...

Read Article

June 25, 2026 07:00 AM

Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a...

Read Article

June 25, 2026 07:00 AM

Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne

German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more than a decade,...

Read Article

May 27, 2026 07:00 AM

Why Merck & Co. Is Rebuilding Clinical Research Around AI

Merck is using AI to redesign clinical trials, patient recruitment, and operational workflows across global pharmaceutical research.

Read Article

April 22, 2026 09:52 PM

Pharma Giant Merck and Google Cloud Sign $1B Agentic AI Deal

Merck has struck a multi-year deal with Google Cloud worth up to $1 billion to enhance the pharmaceutical and life sciences giant's digital backbone "as an.

Read Article

April 22, 2026 07:00 AM

Merck inks Google Cloud agentic AI deal worth up to $1 billion

Merck will build an agentic AI platform on Google Cloud across its research and development, manufacturing, commercial operations and...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-9044

SUMMARY

An OS command injection vulnerability exists in the VPN module of TP-Link AXE75 V1 routers. This vulnerability allows an adjacent, authenticated attacker to execute arbitrary commands on the device by importing a specially crafted VPN client configuration file. The issue arises from improper filtering of special characters. Successful exploitation of this vulnerability may enable an attacker to gain full control of the affected device, potentially compromising configuration integrity, network security, and service availability.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: )

cvss4

Base Score: 8.5

Complexity: LOW

CVSS:4.0/AV:A/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-54909

SUMMARY

pion/stun is a Go implementation of STUN. Prior to 3.1.3, XORMappedAddress.GetFromAs can panic while parsing a malformed short XOR-MAPPED-ADDRESS attribute in STUN or ICE Binding-response parsing paths, allowing remote denial of service. This issue is fixed in version 3.1.3.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-54785

SUMMARY

gemini-bridge is a lightweight MCP server bridging AI agents to Google's Gemini AI via the official CLI. From 1.0.0 until 1.3.1, consult_gemini_with_files in inline mode read any file path supplied in the files argument without confining it to the working directory, then forwarded the contents to the Gemini CLI. Because the caller also controls query, the file contents are echoed back through the Gemini round-trip (and sent to Google), making this an arbitrary local file read. This issue is fixed in version 1.3.1.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: 6.2)

cvss3

Base Score: 6.2

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.5

REFERENCES

CVE-2026-54768

SUMMARY

WPGraphQL provides a GraphQL API for WordPress sites. From 2.0.0 until 2.15.1, the deprecated user field on SendPasswordResetEmailPayload lets an unauthenticated caller distinguish existing author-class accounts through the sendPasswordResetEmail mutation and obtain public profile fields. This issue is fixed in version 2.15.1.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-53573

SUMMARY

GeoNetwork is a catalog application to manage spatially referenced resources. From 3.12.0 until 4.2.16 and 4.4.11, unsafe redirect validation in GeonetworkOAuth2LoginAuthenticationFilter and KeycloakAuthenticationProcessingFilter permits an attacker-controlled external redirect after login. This issue is fixed in versions 4.2.16 and 4.4.11.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: )

cvss4

Base Score: 4.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…